Hong Kong Bioinformatics Market Analysis Report [2022-30] I Insights10

Hong Kong Bioinformatics Market Analysis

$ 3999

The Hong Kong Bioinformatics market is projected to grow from $24.6 Mn in 2022 to $88.15 Bn by 2030, registering a CAGR of 17.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be strong research and development, active support from the government, and the growing healthcare industry. Some of the major players include Beth Bioinformatics (HKG), L3Bioinformatics Ltd. (HKG), Genvida (HKG), IBM Life Sciences, and Qiagen.

ID: IN10HKHS001 CATEGORY: Healthcare Services GEOGRAPHY: Hong Kong AUTHOR: Neha Davda

Buy Now

Hong Kong Bioinformatics Market Executive Summary

The Hong Kong Bioinformatics market is projected to grow from $24.6 Mn in 2022 to $88.15 Bn by 2030, registering a CAGR of 17.30% during the forecast period of 2022 - 2030. In Hong Kong, the total health expenditure amounted to $189,624 million in 2019-20, with annual per capita spending at $25,258 forming 6.8% of its GDP. The healthcare system in Hong Kong offers service quality and health systems that rank well by worldwide norms at relatively modest current health and public current health expenditures as percentages of GDP (6.5% and 3.4%, respectively, in 2019-20), demonstrating cost-effectiveness and efficiency.

Bioinformatics helps researchers to interpret and identify patterns in biological data by fusing computer programming, large data, and molecular biology. The ability to organize data makes it particularly useful for researchers looking into genomes and DNA sequencing. One of the most exciting areas of biology is bioinformatics, which aids in finding, evaluating, storing, and retrieving biological data. It integrates multiple applications of Biology, Computer Science, and Statistics to produce software applications for understanding biological data, including DNA sequencing, protein analysis, evolutionary genetics, and others. The bioinformatics industry in Hong Kong is expanding, and numerous businesses, academic institutions, and governmental organizations are actively engaged in bioinformatics research and development.

hong kong bioinformatics market analysis

Market Dynamics

Market Growth Drivers

The Hong Kong bioinformatics market is expected to be driven by factors such as strong research and development which provides a foundation for the growth of the bioinformatics market and active support from the government. Moreover, the growing healthcare industry is also increasing the demand for bioinformatics for new drug discovery and precision medicine.

Market Restraints

Without adequate funding, bioinformatics research and development can be expensive and as it relies on large amounts of data, not having proper data-sharing agreements and infrastructure is restricting the growth of the bioinformatics market in Hong Kong.

Competitive Landscape

Key Players

Beth Bioinformatics (HKG)
L3 Bioinformatics (HKG)
Genvida (HKG)
IBM Life Sciences
Qiagen

Healthcare Policies and Regulatory Landscape

The healthcare system and regulatory environment in Hong Kong are comparatively open and supportive. Anyone who resides in Hong Kong is entitled to free public healthcare, including non-permanent residents as long as they have a valid in-date. The government of the Hong Kong special administrative region has invested a lot in creating a solid healthcare system. The Health Bureau is in charge of developing policies and distributing funds for the administration of Hong Kong's healthcare system. Additionally, it guarantees that these regulations are carried out successfully to safeguard and advance public health and to give all Hong Kong residents access to lifelong holistic healthcare. The Department of Health (DH) is the government's health adviser and the body responsible for carrying out statutory duties and healthcare policy. Through a variety of promotional, preventive, curative, and rehabilitative services, it protects the community's health. DH offers Hong Kong residents discounted access to healthcare through its centres and clinics. Additionally, it also oversees and controls how bioinformatics is applied in the healthcare sector, including the creation and application of genetic testing and other related technologies.

Reimbursement Scenario

Hong Kong has a public and private healthcare system, both of which are held to very high standards. Employers or private insurance providers are typically the ones who offer reimbursement programmes for medical expenses. Through the Hospital Authority and the Community Health Assistance Scheme (CHAS), the government also provides financial aid for people who cannot afford medical care. Hong Kong's public healthcare system, which was modelled after the British National Health System, is centralised, supports universal access to healthcare, and is essentially free inside public health institutions. Additionally, the Comprehensive Social Security Assistance (CSSA) programme may be able to provide additional assistance to some groups, such as the elderly and low-income families.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.